Tie-2

Inhibitory Selectivity
Catalog No.Inhibitor Name Tie-2Other
A10996Cabozantinib
***
VEGFR2/KDR,c-Met,Kit
A10587MGCD-265
****
Met,RON,VEGFR2
A10932Tie2 kinase inhibitor
**
A13456AMG-Tie2-1
****
A10895Pexmetinib (ARRY-614)
p38 MAPK
A14387Altiratinib (DCC2701)

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

6 个项目

每页

设置升序顺序
Catalog No. Product Name Application Product Information
A10996 SALE

XL184 free base (Cabozantinib)

VEGFR 抑制剂
XL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2.
A10587

MGCD-265 (Glesatinib)

c-Met 抑制剂
MGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R.
A10932

Tie2 kinase inhibitor

-
Tie2 kinase inhibitor is a potent and selective Tie2 inhibitor with IC50 of 0.25 μM.
A13456

AMG-Tie2-1

Tie-2 抑制剂
AMG-Tie2-1 is a highly potent, non-selective inhibitor of Tie-2 (IC50 <1 nM).
A14387

Altiratinib (DCC2701)

c-Met/VEGFR 抑制剂
Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro.
A10895

Pexmetinib (ARRY-614)

p38 MAPK 抑制剂
Pexmetinib is a potent inhibitor of cytokine synthesis, via the dual inhibition of p38 mitogen-activated protein kinase (MAPK), and Tie2/Tek receptor tyrosine kinase.

6 个项目

每页

设置升序顺序